You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Blast Crisis

Showing 51 - 75 of 1,113
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ph+ Acute Lymphoblastic Leukemia (Ph+ALL), Ph- Acute Lymphoblastic Leukemia (Ph-ALL), Chronic Myeloid Leukemia Accelerated Phase

Withdrawn
  • Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)
  • +3 more
  • Atlanta, Georgia
  • +5 more
Oct 23, 2018

Leukemia Trial in Worldwide (Dasatinib)

Active, not recruiting
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +173 more
Dec 1, 2022

Chronic Myeloid Leukemia Trial in Italy (Nilotinib)

Completed
  • Chronic Myeloid Leukemia
  • Ascoli Piceno, Italy
  • +21 more
Jan 3, 2022

Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

Completed
  • Hematopoietic/Lymphoid Cancer
  • +135 more
  • beclomethasone dipropionate
  • +4 more
  • Hackensack, New Jersey
  • +1 more
Feb 1, 2021

mTBI Trial in Boston (Auditory gamma sensory stimulation)

Recruiting
  • mTBI
  • Auditory gamma sensory stimulation
  • Boston, Massachusetts
    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Jul 7, 2022

Leukemia, Myeloid, Acute Trial in Seoul (Idarubicin)

Recruiting
  • Leukemia, Myeloid, Acute
  • Seoul, Korea, Republic of
    Division of Hematology-Oncology, Konkuk University Medical Cente
Apr 8, 2022

Chronic Myelogenous Leukemia - Chronic Phase Trial in China (Dasatinib Tablets)

Completed
  • Chronic Myelogenous Leukemia - Chronic Phase
  • Dasatinib Tablets
  • Shenzhen, Guangdong, China
  • +3 more
Jun 11, 2021

Chronic Myelogenous Leukemia Trial in Worldwide (ABL001 40mg BID, ABL001 80mg QD, ABL001 200mg QD)

Recruiting
  • Chronic Myelogenous Leukemia
  • ABL001 40mg BID
  • +2 more
  • Caba, Buenos Aires, Argentina
  • +53 more
Jan 27, 2023

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission Trial

Recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
  • Houston, Texas
  • +3 more
Jan 25, 2022

Familial Dysautonomia Trial in New York (Matching , Dexmedetomidine)

Not yet recruiting
  • Familial Dysautonomia
  • New York, New York
    NYU Langone Health
Nov 20, 2023

Early Digital, Analyte and Neurologic Biomarkers of Acute and

Enrolling by invitation
  • Traumatic Brain Injury
    • Fort Bragg, North Carolina
      Ft. Bragg
    Jun 14, 2023

    Needs of 3L+ CP-CML and With T315I-mutated CML Patients

    Completed
    • Chronic Myeloid Leukemia
    • 3L Therapy
    • T315I
    • Lyon, France
      Novartis Investigative Site
    Nov 9, 2022

    Identify Biomarkers Associated With Chronic Traumatic Brain

    Completed
    • Traumatic Brain Injury
    • Blood/saliva sampling
    • Houston, Texas
      TIRR
    Sep 9, 2022

    Familial Dysautonomia Trial in New York (Dexmedetomidine Sublingual)

    Not yet recruiting
    • Familial Dysautonomia
    • Dexmedetomidine Sublingual
    • New York, New York
      NYU Langone Health
    Nov 7, 2023

    Chronic Myeloid Leukemia Trial in Germany, Netherlands (TKI discontinuation, nilotinib)

    Active, not recruiting
    • Chronic Myeloid Leukemia
    • Freiburg, Baden-Württemberg, Germany
    • +14 more
    Nov 4, 2021

    Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia

    Not yet recruiting
    • Tyrosine Kinase Inhibitor
    • +2 more
      • Taipei, Taiwan
        National Taiwan University Hospital
      Feb 17, 2022

      MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Pevonedistat)

      Completed
      Has Results
      • Myelodysplastic Syndromes
      • +2 more
      • Birmingham, Alabama
      • +58 more
      Aug 24, 2022

      Quality of Telephone Calls to a Suicide Prevention Helpline

      Completed
      • Suicide Prevention
      • Suicidal Ideation
        • Brussels, Belgium
          Centre for Suicide Prevention
        Nov 14, 2023

        Suicidal Ideation, Treatment Refusal, Emotion Regulation Trial in Columbus (Crisis Response Planning and Lethal Means Safety

        Recruiting
        • Suicidal Ideation
        • +2 more
        • Crisis Response Planning and Lethal Means Safety Counseling
        • Columbus, Ohio
          The Ohio State University Wexner Medical Center
        Feb 9, 2023

        Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

        Terminated
        Has Results
        • Adult Acute Megakaryoblastic Leukemia (M7)
        • +16 more
        • metformin hydrochloride
        • +2 more
        • Chicago, Illinois
          Northwestern University
        Jan 8, 2019

        Suicide Trial in Ann Arbor (Crisis Line Facilitation (CLF), Passive Implementation)

        Not yet recruiting
        • Suicide
        • Crisis Line Facilitation (CLF)
        • Passive Implementation
        • Ann Arbor, Michigan
          University of Michigan
        Jan 23, 2023

        Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

        Completed
        Has Results
        • Chronic Myeloid Leukemia
        • Omacetaxine mepesuccinate
        • Los Angeles, California
        • +28 more
        Dec 1, 2021

        Immunophenotyping of Blast Cells and Immune Effector Cells in

        Completed
        • Leukemia
        • Blood and Marrow sample
        • Marseille, France
          Assistance Publique - Hopitaux de Marseille
        Jan 23, 2023

        Autism Spectrum Disorder, Behavior Problem Trial in Baltimore (Crisis Prevention Arm, Control)

        Not yet recruiting
        • Autism Spectrum Disorder
        • Behavior Problem
        • Crisis Prevention Arm
        • Control
        • Baltimore, Maryland
          Kennedy Krieger Institute
        Jan 9, 2023

        Impact of the Coronavirus Health Crisis on Psychotropic Drug Use

        Not yet recruiting
        • Psychotropic Drugs
          • (no location specified)
          Jun 3, 2022